Affidea B.V., headquartered in the Netherlands, is a leading provider in the healthcare sector, specialising in diagnostic imaging, outpatient care, and cancer treatment. Founded in 1991, the company has expanded its operations across Europe, establishing a strong presence in multiple countries. Affidea is renowned for its advanced imaging technologies and patient-centric services, which include MRI, CT scans, and radiology. The company’s commitment to innovation and quality care has positioned it as a trusted partner in the healthcare industry. With a focus on enhancing patient experiences and outcomes, Affidea continues to achieve significant milestones, solidifying its reputation as a market leader in integrated healthcare solutions.
How does Affidea B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Affidea B.V.'s score of 50 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Affidea B.V., headquartered in the Netherlands, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Groupe Bruxelles Lambert SA, which may influence its climate commitments and reporting practices. While there are no documented reduction targets or specific climate pledges from Affidea B.V., it is important to note that any climate initiatives or targets would likely be aligned with those set by its parent company, Groupe Bruxelles Lambert SA. This relationship suggests that Affidea B.V. may be working towards broader sustainability goals as part of its corporate family. As of now, Affidea B.V. has not disclosed any specific initiatives or commitments related to the Science Based Targets initiative (SBTi) or other climate frameworks. The absence of emissions data and reduction targets highlights a potential area for improvement in transparency and accountability regarding their environmental impact.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 150,000 | 000,000 | 000,000 | 000,000 | 000,000 | 000,000,000 |
| Scope 2 | 70,000 | 00,000 | 00,000 | 00,000 | 0,000 | 0,000,000 |
| Scope 3 | 11,514,000,000 | 00,000,000,000 | 0,000,000,000 | 000,000 | 000,000 | 00,000,000,000,000 |
Affidea B.V.'s Scope 3 emissions, which increased significantly last year and increased significantly since 2019, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 100% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Affidea B.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.